OpenLegislation

Introductory text

United Kingdom

Original text. Later amendments are not shown.

F1Commission Regulation (EC) No 847/2000

of 27 April 2000

laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts ‘similar medicinal product’ and ‘clinical superiority’ (revoked)

Annotations

Textual amendments

F1

Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(g) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)